GZMA and Miyoshi myopathy: In high-risk SMM patients, 155 upregulated genes included molecules associated to MM (TNFRSF17, NCAM1, IRF4, CD79B), cytotoxic molecules (KLRC1, GZMA) and AXL (Figure 5C).